SOLIRIS
NDC 25682-001, ECULIZUMAB, injection, solution, concentrate, from Alexion Pharmaceuticals Inc..
- Product NDC
- 25682-001
- Status
- Listed
- Labeler
- Alexion Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125166
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25682-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ECULIZUMAB300 mg/30mL
Pharmacologic classes
Complement Inhibitor [EPC]; Complement Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25682-001-01 | 25682000101 | 1 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25682-001
Use it
Look up 25682-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25682-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25682-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.